Sixiang Yu

1.7k total citations
7 papers, 232 citations indexed

About

Sixiang Yu is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sixiang Yu has authored 7 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Sixiang Yu's work include Ubiquitin and proteasome pathways (2 papers), MicroRNA in disease regulation (2 papers) and Autoimmune Neurological Disorders and Treatments (1 paper). Sixiang Yu is often cited by papers focused on Ubiquitin and proteasome pathways (2 papers), MicroRNA in disease regulation (2 papers) and Autoimmune Neurological Disorders and Treatments (1 paper). Sixiang Yu collaborates with scholars based in United States and China. Sixiang Yu's co-authors include Xiaolu Yang, Joshua D. Rabinowitz, Yi Xu, Y Zhang, Ian A. Blair, Juan Carlos García‐Cañaveras, Lili Guo, Mengyuan Kan, Zeyu Chen and Makoto Kurachi and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Sixiang Yu

7 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sixiang Yu United States 6 152 47 43 42 33 7 232
Zuzana Nahácka Czechia 9 174 1.1× 43 0.9× 25 0.6× 26 0.6× 31 0.9× 11 251
Marina Badenes Portugal 8 176 1.2× 45 1.0× 30 0.7× 46 1.1× 28 0.8× 14 307
Yu Shen China 7 198 1.3× 61 1.3× 24 0.6× 35 0.8× 18 0.5× 9 257
Federica Fusella Italy 9 171 1.1× 39 0.8× 14 0.3× 37 0.9× 37 1.1× 12 230
Andrew Nickless United States 6 222 1.5× 25 0.5× 23 0.5× 52 1.2× 18 0.5× 9 281
Aida Rodríguez López Denmark 7 279 1.8× 25 0.5× 33 0.8× 27 0.6× 28 0.8× 9 321
Kuanxiang Sun China 10 274 1.8× 107 2.3× 35 0.8× 35 0.8× 52 1.6× 27 347
Kyla D. Baron Canada 7 217 1.4× 40 0.9× 90 2.1× 25 0.6× 59 1.8× 7 324
Leentje De Ceuninck Belgium 9 148 1.0× 21 0.4× 52 1.2× 49 1.2× 45 1.4× 10 269
Gürkan Mollaoglu United States 5 92 0.6× 27 0.6× 29 0.7× 63 1.5× 33 1.0× 5 222

Countries citing papers authored by Sixiang Yu

Since Specialization
Citations

This map shows the geographic impact of Sixiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixiang Yu more than expected).

Fields of papers citing papers by Sixiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixiang Yu. The network helps show where Sixiang Yu may publish in the future.

Co-authorship network of co-authors of Sixiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Sixiang Yu. A scholar is included among the top collaborators of Sixiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sixiang Yu. Sixiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Alikarami‬, Fatemeh, Simone S. Riedel, Sarah K. Tasian, et al.. (2025). Upfront menin-inhibitor resistance in multiply pretreated leukemias. Experimental Hematology. 153. 105268–105268. 1 indexed citations
2.
Zhang, Y, Yi Xu, Wenyun Lu, et al.. (2022). G6PD-mediated increase in de novo NADP + biosynthesis promotes antioxidant defense and tumor metastasis. Science Advances. 8(29). eabo0404–eabo0404. 36 indexed citations
3.
Huang, Liangqian, Guixin Zhu, Sixiang Yu, et al.. (2021). DAXX represents a new type of protein-folding enabler. Nature. 597(7874). 132–137. 57 indexed citations
4.
Xu, Yi, Y Zhang, Juan Carlos García‐Cañaveras, et al.. (2020). Chaperone-mediated autophagy regulates the pluripotency of embryonic stem cells. Science. 369(6502). 397–403. 72 indexed citations
5.
Weng, Liwei, Qingqing Wang, Sixiang Yu, et al.. (2019). Evaluation of antibodies for western blot analysis of frataxin protein isoforms. Journal of Immunological Methods. 474. 112629–112629. 5 indexed citations
6.
Wang, Fang, Kailiang Zhao, Sixiang Yu, et al.. (2018). RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III–dependent transcription. Journal of Biological Chemistry. 294(1). 130–141. 7 indexed citations
7.
Chen, Zeyu, Erietta Stelekati, Makoto Kurachi, et al.. (2017). miR-150 Regulates Memory CD8 T Cell Differentiation via c-Myb. Cell Reports. 20(11). 2584–2597. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026